-
Regis Technologies’ 2019 FDA Inspection Yields NAI Classification (Zero 483s)
cphi-online
May 06, 2019
Regis Technologies, a contract development and manufacturing organization for small molecule active pharmaceutical ingredients, earned perfect results from its April 2019 FDA inspection.
-
BioPure Q-Clamp is compatible with a wide range of connector geometries
europeanpharmaceuticalreview
May 06, 2019
The latest innovation from Watson-Marlow Fluid Technology Group brand BioPure is the Q‑Clamp, a new sanitary Tri-Clamp® for single-use fluid path applications…
-
Primary Care Constitutes Minority of Research Funded by PCORI
drugs
May 06, 2019
Primary Care Constitutes Minority of Research Funded by PCORI...
-
Project Hercules to lead way in Duchenne muscular dystrophy
europeanpharmaceuticalreview
April 30, 2019
Pharmaceutical companies are sponsoring a project to generate, align and share disease-level data across an entire condition for health technology assessments…
-
Merck KGaA: Allergopharma Plans to Invest € 40 Million in Production Facility
americanpharmaceuticalreview
April 29, 2019
The German pharmaceutical, chemical and life science company Merck KGaA, Darmstadt, Germany, broke ground today on a new production facility for its Allergopharma unit in Reinbek near Hamburg.
-
Pharmaceutical and Biotech sectors to drive investments in the APAC Healthcare Industry, predicts Frost & Sullivan
biospectrumasia
April 28, 2019
Digital technology advancements and medical tourism enhance growth opportunities in the region
-
Taking the difficulty out of API process filtration
europeanpharmaceuticalreview
April 28, 2019
Taking the difficulty out of API process filtration.
-
Drug prices come under fire as US pharma lobby nears spending records
drugs
April 25, 2019
More ambitious changes may be needed to lower pharmaceutical prices as the Trump administration proposes new rules and approves a slew of new generic drugs.
-
Ipsen closes $1bn Clementia Pharmaceuticals acquisition
pharmaceutical-technology
April 24, 2019
Ipsen has completed an acquisition of Canada-based Clementia Pharmaceuticals to expand its rare diseases portfolio.
-
Roche reports a strong start in 2019 and raises the outlook for the full-year
worldpharmanews
April 23, 2019
Roche reports a strong start in 2019 and raises the outlook for the full-year...